2026 Mid-Career Research Award - Final Reminder LOIs Due Soon

There’s still time to apply! The HTRS Awards Committee invites final Letters of Intent for the 2026 Mid-Career Research Award (MCRA). This award provides $216,000 in funding over two years to support clinical, translational, or basic science research in hemostasis and/or thrombosis. 

Designed for clinicians, physician-scientists, or discovery-based scientists (MDs, DOs, PhDs, or MD/PhDs) with 5–15 years of academic research experience, the MCRA helps recipients progress to full research independence and R01-equivalent funding.

Total Award: $216,000 (two-year project)

Letters of Intent Due: Friday, October 24, 2025 at 11:59 PM ET

Eligibility (summary): Doctoral degree (MD, DO, PhD, MD/PhD or equivalent); academic faculty position in the U.S. or Canada; prior career development award funding; working toward first R01 (or equivalent) in the U.S. or Canada; and HTRS Core-level membership in good standing at the time of application. 

📄 View the full Request for Applications (RFA) for complete eligibility, submission instructions, and review criteria. 

Access the HTRS Grant Submission Site by clicking here.

Applicants should demonstrate how the MCRA will support an R01 (or equivalent) submission in the U.S. or Canada. 

Questions? Reach out to our Awards Program Manager at [email protected].